Potassium-Lowering Effect of Mineralocorticoid Therapy in Patients Undergoing Hemodialysis

Publisher： Karger

E-ISSN： 2235-3186|92|3|576-581

ISSN： 1660-8151

Source： Nephron, Vol.92, Iss.3, 2002-09, pp. : 576-581

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

No Effect of Losartan on Response to Erythropoietin Therapy in Patients Undergoing Hemodialysis

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 538-539

Karger

Access to resources Recommend Favorite

Psychiatric Disorders among Patients Undergoing Hemodialysis Therapy

By  

Nephron, Vol. 91, Iss. 2, 2002-06 ,pp. : 344-347

Karger

Access to resources Recommend Favorite

Hepatitis G and Erythropoietin Therapy in Patients Undergoing Hemodialysis

By  

Nephron, Vol. 79, Iss. 4, 1998-07 ,pp. : 507-507

Karger

Access to resources Recommend Favorite

Effects of Lowering Dialysate Calcium Concentration on Carotid Intima-Media Thickness and Aortic Stiffness in Patients Undergoing Maintenance Hemodialysis: A Prospective Study

By  

Blood Purification, Vol. 42, Iss. 4, 2016-11 ,pp. : 337-346

Karger

Access to resources Recommend Favorite

Procalcitonin in Patients Undergoing Chronic Hemodialysis

By  

Nephron, Vol. 84, Iss. 2, 2000-01 ,pp. : 187-188

Karger

Access to resources Recommend Favorite